SCHEMBL25948348

SCHEMBL25948348

O=C(OCCOCCCc1ccccc1)c1cccnc1

nearest known ligand 0.64

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.64
KMT2A Q03164 4/20 0.64
TDP1 Q9NUW8 1/20 0.64
L3MBTL1 Q9Y468 1/20 0.59
EPHX2 P34913 1/20 0.55
CHRNA7 P36544 1/20 0.52
MEN1 O00255 2/20 0.51
NPC1 O15118 1/20 0.51
RAB9A P51151 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
MAPT P10636 3/20 0.49
GPR52 Q9Y2T5 1/20 0.49
ALDH1A1 P00352 4/20 0.48
KDM4E B2RXH2 3/20 0.48
HPGD P15428 1/20 0.48
TBXAS1 P24557 1/20 0.48
GAA P10253 1/20 0.48
ALOX15 P16050 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25948396 0.95 KMT2A (0.61) LMNAKMT2ATDP1L3MBTL1EPHX2
SCHEMBL14219781 0.88 LMNA (0.73) LMNAKMT2ATDP1L3MBTL1EPHX2
Nicoboxil SCHEMBL14917483 0.86 TDP1 (0.70) LMNAKMT2ATDP1L3MBTL1EPHX2
SCHEMBL5363082 0.84 LMNA (0.71) LMNAKMT2ATDP1L3MBTL1MEN1
SCHEMBL25945540 0.84 LMNA (0.52) LMNAKMT2ATDP1L3MBTL1EPHX2
SCHEMBL25329932 0.84 L3MBTL1 (0.62) LMNAKMT2ATDP1L3MBTL1MEN1
Nicoboxil SCHEMBL29475326 0.84 L3MBTL1 (0.84) LMNAKMT2ATDP1L3MBTL1MEN1
Nicoboxil SCHEMBL288321 0.84 L3MBTL1 (0.84) LMNAKMT2ATDP1L3MBTL1MEN1
SCHEMBL25330051 0.84 LMNA (0.56) LMNAKMT2ATDP1L3MBTL1MEN1
SCHEMBL25951686 0.83 KMT2A (0.51) LMNAKMT2ATDP1L3MBTL1EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023147161-A2 NICOTINATE AND NICOTINAMIDE RIBOSIDE-BASED COMPOUNDS AND DERIVATIVES THEREOF New Frontier Bio, Inc. (US) 2023-08-03 WO disclosed